← Leaderboards
Lee Ratner
Washington University
$26,026,037
Attributed
$27,567,045
Total exposure
28
Grants
21
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$29,538,106 · 29
By mechanism
R01$8,992,667 · 7
P01$8,734,774 · 6
T32$4,924,260 · 1
R21$4,355,883 · 10
P50$2,482,735 · 3
P51$47,787 · 1
Top collaborators
- Daniel Arthur Rauch10 shared
- Sebla B. Kutluay2 shared
Most similar at Washington University
Same institution · by research overlap
- Helen M Piwnica-Worms$9,529,923
- Vijay Sharma$15,781,488
- Reece Joseph Goiffon$86,081
- Vaishali Kapoor$459,633
- Paula M Fracasso$1,120,427
Others in their field
Top investigators on “Human T-Lymphotropic Virus 1”
- Greg Westergaard · Alpha Genesis, Inc.$10,419,039
- Edward L Murphy · University Of California San Francisco$9,421,647
- Carlos A Sariol · University Of Puerto Rico Med Sciences$9,283,420
- Melween I. Martinez · University Of Puerto Rico Med Sciences$7,760,429
- Edmundo Nelson Kraiselburd · University Of Puerto Rico Med Sciences$7,607,903
- Michael J. Mustari · Emory University$7,158,035
Research focus
Human T-Lymphotropic Virus 1PathogenesisTumorigenesisMalignant NeoplasmsCellsMolecularMediatingTaxesTumorLymphomaCell LineMouse ModelMutationT-LymphocyteApoptosisPathway InteractionsViralAnimal ModelVirusInfectionAdult T-Cell Leukemia/LymphomaGenesLeukemia/LymphomaAnimals
Grant awards (113)
Retrovirus Models of Cancer$1,971,061
P01 · FY2025 · CA · contact PI
Project 3: Epigenomic Regulation of HTLV-1 Reactivation & Pathogenesis$493,051
P01 · FY2025 · CA · contact PI
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma$360,282
R01 · FY2025 · CA · contact PI
Core A: Administrative Core$93,300
P01 · FY2025 · CA · contact PI
Molecular Oncology Training Grant$497,280
T32 · FY2024 · CA · contact PI
Project 3: Role of CTCF in HTLV-1 Replication and Transformation$422,628
P01 · FY2024 · CA · contact PI
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma$342,267
R01 · FY2024 · CA · contact PI
Molecular Oncology Training Grant$480,656
T32 · FY2023 · CA · contact PI
Project 3: Role of CTCF in HTLV-1 Replication and Transformation$440,485
P01 · FY2023 · CA · contact PI
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma$353,076
R01 · FY2023 · CA · contact PI
Allosteric integrase inhibitor effects on human T-cell leukemia virus infection$195,626
R21 · FY2023 · AI · contact PI
Project 3: Role of CTCF in HTLV-1 Replication and Transformation$431,675
P01 · FY2022 · CA · contact PI
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma$360,282
R01 · FY2022 · CA · contact PI
MOLECULAR ONCOLOGY TRAINING GRANT$350,387
T32 · FY2022 · CA · contact PI
Single-Cell Transcriptome & Effect of Immune Checkpoint Therapy on Kaposi Sarcoma$236,250
R21 · FY2022 · CA · contact PI
Allosteric integrase inhibitor effects on human T-cell leukemia virus infection$236,250
R21 · FY2022 · AI · contact PI
Interaction of HTLV-1 Tax & Hbz in Transformation$216,476
R21 · FY2022 · CA · contact PI
Role of Protein Kinase C Mutations in Adult T-Cell Leukemia$216,476
R21 · FY2022 · CA · contact PI
Project 3: Role of CTCF in HTLV-1 Replication and Transformation$373,491
P01 · FY2021 · CA · contact PI
MOLECULAR ONCOLOGY TRAINING GRANT$265,669
T32 · FY2021 · CA · contact PI
Single-Cell Transcriptome & Effect of Immune Checkpoint Therapy on Kaposi Sarcoma$196,875
R21 · FY2021 · CA · contact PI
Role of Protein Kinase C Mutations in Adult T-Cell Leukemia$184,078
R21 · FY2021 · CA · contact PI
Interaction of HTLV-1 Tax & Hbz in Transformation$184,078
R21 · FY2021 · CA · contact PI
Project 3: Role of CTCF in HTLV-1 Replication and Transformation$387,491
P01 · FY2020 · CA · contact PI
MOLECULAR ONCOLOGY TRAINING GRANT$213,013
T32 · FY2020 · CA · contact PI
IMMUNE CHECKPOINT BLOCKADE PROMOTES ADULT T CELL LEUKEMIA$205,157
R21 · FY2020 · CA · contact PI
MOLECULAR ONCOLOGY TRAINING GRANT$342,884
T32 · FY2019 · CA · contact PI
IMMUNE CHECKPOINT BLOCKADE PROMOTES ADULT T CELL LEUKEMIA$169,786
R21 · FY2019 · CA · contact PI
Project 4: Tumorigenic Effects of Tax$438,117
P01 · FY2018 · CA · contact PI
MOLECULAR ONCOLOGY TRAINING GRANT$331,242
T32 · FY2018 · CA · contact PI
Project 4: Tumorigenic Effects of Tax$18,280
P01 · FY2018 · CA · contact PI
Project 4: Tumorigenic Effects of Tax$436,430
P01 · FY2017 · CA · contact PI
ROLE OF CTCF IN HTLV-1 PATHOGENESIS$242,475
R21 · FY2017 · AI · contact PI
PROLIFERATIVE EFFECTS OF HTLV-1$158,641
R01 · FY2017 · CA · contact PI
Developmental Research Program$76,258
P50 · FY2017 · CA · contact PI
Molecular Oncology Training Grant$6,143
T32 · FY2017 · CA · contact PI
Molecular Oncology Training Grant$3,719
T32 · FY2017 · CA · contact PI
Project 4: Tumorigenic Effects of Tax$437,669
P01 · FY2016 · CA · contact PI
Molecular Oncology Training Grant$307,754
T32 · FY2016 · CA · contact PI
ROLE OF CTCF IN HTLV-1 PATHOGENESIS$190,625
R21 · FY2016 · AI · contact PI
PROLIFERATIVE EFFECTS OF HTLV-1$158,641
R01 · FY2016 · CA · contact PI
Imaging NFkB Activation in HTLV Lymphoma$101,413
P50 · FY2016 · CA · contact PI
Developmental Research Program$71,683
P50 · FY2016 · CA · contact PI
Project 4: Tumorigenic Effects of Tax$433,132
P01 · FY2015 · CA · contact PI
Molecular Oncology Training Grant$276,442
T32 · FY2015 · CA · contact PI
PROLIFERATIVE EFFECTS OF HTLV-1$158,641
R01 · FY2015 · CA · contact PI
Developmental Research Program$125,204
P50 · FY2015 · CA · contact PI
Imaging NFkB Activation in HTLV Lymphoma$112,629
P50 · FY2015 · CA · contact PI
Project 4: Tumorigenic Effects of Tax$419,534
P01 · FY2014 · CA · contact PI
HIV CORECEPTOR SHIFT$190,000
R01 · FY2014 · AI · contact PI
Imaging NFkB Activation in HTLV Lymphoma$156,626
P50 · FY2014 · CA · contact PI
PROLIFERATIVE EFFECTS OF HTLV-1$153,882
R01 · FY2014 · CA · contact PI
Developmental Research Program$132,832
P50 · FY2014 · CA · contact PI
Molecular Oncology Training Grant$78,693
T32 · FY2014 · CA · contact PI
Molecular Oncology Training Grant$230,070
T32 · FY2013 · CA · contact PI
HIV CORECEPTOR SHIFT$214,320
R01 · FY2013 · AI · contact PI
PROLIFERATIVE EFFECTS OF HTLV-1$158,641
R01 · FY2013 · CA · contact PI
Imaging NFkB Activation in HTLV Lymphoma$139,034
P50 · FY2013 · CA · contact PI
Developmental Research Program$123,297
P50 · FY2013 · CA · contact PI
Role of Inflammation in Tax-mediated Tumorigenesis$404,581
P01 · FY2012 · CA · contact PI
Molecular Oncology Training Grant$283,333
T32 · FY2012 · CA · contact PI
CELLULAR RESTRICTIVE FACTOR TARGETED BY VIRAL PROTEIN X$228,000
R21 · FY2012 · AI · contact PI
Imaging NFkB Activation in HTLV Lymphoma$116,457
P50 · FY2012 · CA · contact PI
Role of Inflammation in Tax-mediated Tumorigenesis$403,821
P01 · FY2011 · CA · contact PI
Res Proj 3: Imaging HTLV-1 Tax Induced Lymphomas$258,043
P50 · FY2011 · CA · contact PI
CELLULAR RESTRICTIVE FACTOR TARGETED BY VIRAL PROTEIN X$190,000
R21 · FY2011 · AI · contact PI
Role of Inflammation in Tax-mediated Tumorigenesis$418,523
P01 · FY2010 · CA · contact PI
Proliferative Effects of HTLV-1$317,369
R01 · FY2010 · CA · contact PI
Res Proj 3: Imaging HTLV-1 Tax Induced Lymphomas$289,485
P50 · FY2010 · CA · contact PI
Molecular Oncology Training Grant$260,084
T32 · FY2010 · CA · contact PI
Role of Inflammation in Tax-mediated Tumorigenesis$412,519
P01 · FY2009 · CA · contact PI
Proliferative Effects of HTLV-1$317,369
R01 · FY2009 · CA · contact PI
Res Proj 3: Imaging HTLV-1 Tax Induced Lymphomas$292,715
P50 · FY2009 · CA · contact PI
Molecular Oncology Training Grant$254,029
T32 · FY2009 · CA · contact PI
Proliferative Effects of HTLV-1$317,369
R01 · FY2008 · CA · contact PI
Role of Inflammation in Tax-mediated Tumorigenesis$298,986
P01 · FY2008 · CA · contact PI
Res Proj 3: Imaging HTLV-1 Tax Induced Lymphomas$241,335
P50 · FY2008 · CA · contact PI
Molecular Oncology Training Grant$234,539
T32 · FY2008 · CA · contact PI
Proliferative Effects of HTLV-1$317,369
R01 · FY2007 · CA · contact PI
Interaction of HIV gp120 & G protein coupled receptors$253,876
R01 · FY2007 · AI · contact PI
Molecular Oncology Training Grant$246,165
T32 · FY2007 · CA · contact PI
Res Proj 3: Imaging HTLV-1 Tax Induced Lymphomas$245,724
P50 · FY2007 · CA · contact PI
SIV VPX: STRUCTURE & FUNCTION$47,787
P51 · FY2007 · RR · contact PI
Proliferative Effects of HTLV-1$327,832
R01 · FY2006 · CA · contact PI
Molecular Oncology Training Grant$262,158
T32 · FY2006 · CA · contact PI
Interaction of HIV gp120 & G protein coupled receptors$261,459
R01 · FY2006 · AI · contact PI
Interaction of HIV gp120 &G protein coupled receptors$267,750
R01 · FY2005 · AI
Chemo/Antiretroviral therapy for HTLV-1 ATLL$204,255
R01 · FY2005 · CA
HTLV Receptor Identification and Characterization$137,700
R21 · FY2005 · CA
HIV/SIV Vpx-Invariant chain Interaction$351,043
R21 · FY2004 · AI
Interaction of HIV gp120 &G protein coupled receptors$267,750
R01 · FY2004 · AI
Chemo/Antiretroviral therapy for HTLV-1 ATLL$204,255
R01 · FY2004 · CA
HTLV Receptor Identification and Characterization$137,700
R21 · FY2004 · CA
PROLIFERATIVE EFFECTS OF HTLV1$334,737
R01 · FY2003 · CA
Chemo/Antiretroviral therapy for HTLV-1 ATLL$272,340
R01 · FY2003 · CA
HIV/SIV Vpx-Invariant chain Interaction$229,500
R21 · FY2003 · AI
PROLIFERATIVE EFFECTS OF HTLV1$326,297
R01 · FY2002 · CA
CHEMO/ANTIRETROVIRAL THERAPY FOR HTLV1 ATLL$281,916
R21 · FY2002 · CA
HIV1 ASSEMBLY MECHANISM AND INHIBITION$254,175
R01 · FY2002 · CA
PHASE I TRIAL OF COL-3 IN HIV RELATED KAPOSI'S SARCOMA$0
M01 · FY2002 · RR
IMAGINH CANCER VIRUSES WITH TAT TRANSDUCIBLE PEPTIDES$0
P50 · FY2002 · CA
IMAGING CANCER VIRUSES WITH TAT TRANSDUCIBLE PEPTIDES$0
P50 · FY2002 · CA
CHEMO/ANTIRETROVIRAL THERAPY FOR HTLV1 ATLL$325,872
R21 · FY2001 · CA
PROLIFERATIVE EFFECTS OF HTLV1$318,527
R01 · FY2001 · CA
HIV VPX/VPR STRUCTURE/FUNCTION$281,508
R01 · FY2001 · AI
HIV1 ASSEMBLY MECHANISM AND INHIBITION$248,174
R01 · FY2001 · CA
INTERACTION OF HIV GP120 AND G PROTEIN COUPLED RECEPTORS$226,476
R01 · FY2001 · AI
PHASE I TRIAL OF COL-3 IN HIV RELATED KAPOSI'S SARCOMA$0
M01 · FY2001 · RR
PROLIFERATIVE EFFECTS OF HTLV1$326,052
R01 · FY2000 · CA
HIV VPX/VPR STRUCTURE/FUNCTION$275,011
R01 · FY2000 · AI
HIV1 ASSEMBLY MECHANISM AND INHIBITION$242,346
R01 · FY2000 · CA
INTERACTION OF HIV GP120 AND G PROTEIN COUPLED RECEPTORS$221,698
R01 · FY2000 · AI
PHASE I TRIAL OF COL-3 IN HIV RELATED KAPOSI'S SARCOMA$0
M01 · FY2000 · RR